On ECHEMI
Home > Drugs > Hangzhou Minsheng Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

  • Founded in:

    1963-11-29
  • Country:

    China China
  • Address:

    No. 36, Linping Avenue, Donghu Street, Linping District, Hangzhou City, Zhejiang Province
  • Tax NO.:

    913301101430685558
  • Registered Funds:

    88.97 million yuan
  • Website:

  • Email:

Related Drugs
Atropine Sulfate Tablets
The main ingredient of this product is: atropine.
Name Description Content CAS NO. Registered Holders
Atropine

Not described in detail

More

Not described in detail

51-55-8 6
Spironolactone tablets
Main ingredients: Spironolactone, chemical name: 17beta;-hydroxy-3-oxy-7alpha;-(acetylthio)-17alpha;-pregnane-4-ene-21-carboxylic acid gamma;-lactone. Its molecular formula: C24H32O4S molecular weight: 416.57
Name Description Content CAS NO. Registered Holders
Spironolactone

This drug has a similar structure to aldosterone and is a competitive inhibitor of aldosterone. It acts on the distal convoluted tubule and collecting duct, blocking the Na+-K+ and Na+-H+ exchanges, resulting in increased excretion of Na+, C1- and water, reduced excretion of K+, Mg2+ and H+, and uncertain effects on Ca2+ and P3-. Since this drug only acts on the distal convoluted tubule and collecting duct, and has no effect on other segments of the renal tubule, its diuretic effect is weak. In addition, this drug also has effects on aldosterone target organs other than the renal tubule.

More

This drug has a similar structure to aldosterone and is a competitive inhibitor of aldosterone. It acts on the distal convoluted tubule and collecting duct, blocking the Na+-K+ and Na+-H+ exchanges, resulting in increased excretion of Na+, C1- and water, reduced excretion of K+, Mg2+ and H+, and uncertain effects on Ca2+ and P3-. Since this drug only acts on the distal convoluted tubule and collecting duct, and has no effect on other segments of the renal tubule, its diuretic effect is weak. In addition, this drug also has effects on aldosterone target organs other than the renal tubule.

52-01-7 18
Magnesium Sulfate Injection
Magnesium sulfate
Name Description Content CAS NO. Registered Holders
Magnesium sulfate

Magnesium ions can inhibit the activity of the central nervous system, inhibit the release of acetylcholine at the motor nerve-muscle junction, block conduction at the neuromuscular junction, reduce or relieve muscle contraction, and at the same time have a dilating effect on vascular smooth muscle, dilate spasmodic peripheral blood vessels, and lower blood pressure. Therefore, it has a preventive and therapeutic effect on eclampsia. It also has an inhibitory effect on uterine smooth muscle contraction and can be used to treat premature delivery.

More

Magnesium ions can inhibit the activity of the central nervous system, inhibit the release of acetylcholine at the motor nerve-muscle junction, block conduction at the neuromuscular junction, reduce or relieve muscle contraction, and at the same time have a dilating effect on vascular smooth muscle, dilate spasmodic peripheral blood vessels, and lower blood pressure. Therefore, it has a preventive and therapeutic effect on eclampsia. It also has an inhibitory effect on uterine smooth muscle contraction and can be used to treat premature delivery.

7487-88-9 33
Fenofibrate Tablets
The main ingredient of this product is fenofibrate. Molecular formula: C20H21ClO4
Name Description Content CAS NO. Registered Holders
Fenofibrate

This product is a blood lipid regulating drug of clofibric acid derivatives. It reduces blood low-density lipoprotein, cholesterol and triglycerides by inhibiting the production of very low-density lipoprotein and triglycerides and increasing their catabolism at the same time; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. This product also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic.

More

This product is a blood lipid regulating drug of clofibric acid derivatives. It reduces blood low-density lipoprotein, cholesterol and triglycerides by inhibiting the production of very low-density lipoprotein and triglycerides and increasing their catabolism at the same time; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. This product also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic.

49562-28-9 63
Potassium Magnesium Aspartate Injection
This product is a compound preparation, and its components are: each 1 ml contains 79-91 mg of aspartic acid, 10.6-12.2 mg of potassium, and 3.9-4.5 mg of magnesium.
Name Description Content CAS NO. Registered Holders
L-ASPARTIC ACID

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

79-91mg 6899-03-2 18
Potassium

As an ion carrier, it enters cells, increases the concentration of potassium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function. It is metabolized and excreted from the body through the kidneys.

More

As an ion carrier, it enters cells, increases the concentration of potassium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function. It is metabolized and excreted from the body through the kidneys.

10.6-12.2mg 0
Magnesium

As an ion carrier, it enters cells, increases the concentration of magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function. It is metabolized and excreted from the body through the kidneys.

More

As an ion carrier, it enters cells, increases the concentration of magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function. It is metabolized and excreted from the body through the kidneys.

3.9-4.5mg 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.